ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,514,669 | +24.8% | 26,088 | +15.7% | 0.00% | +100.0% |
| Q2 2023 | $1,213,975 | +75.3% | 22,552 | +29.3% | 0.00% | 0.0% |
| Q1 2023 | $692,598 | -1.2% | 17,437 | +0.0% | 0.00% | 0.0% |
| Q4 2022 | $701,289 | +55.8% | 17,432 | +24.3% | 0.00% | 0.0% |
| Q3 2022 | $450,000 | +8.7% | 14,021 | +0.5% | 0.00% | – |
| Q2 2022 | $414,000 | +0.2% | 13,951 | -5.1% | 0.00% | – |
| Q1 2022 | $413,000 | -40.0% | 14,699 | -1.3% | 0.00% | – |
| Q4 2021 | $688,000 | -23.9% | 14,895 | -45.9% | 0.00% | – |
| Q3 2021 | $904,000 | -13.2% | 27,541 | -7.3% | 0.00% | -100.0% |
| Q2 2021 | $1,041,000 | +7.1% | 29,708 | +10.4% | 0.00% | – |
| Q1 2021 | $972,000 | +7.5% | 26,910 | -13.5% | 0.00% | – |
| Q4 2020 | $904,000 | +15.6% | 31,109 | +12.1% | 0.00% | – |
| Q3 2020 | $782,000 | -43.6% | 27,748 | -35.3% | 0.00% | -100.0% |
| Q2 2020 | $1,387,000 | +106.4% | 42,908 | +159.8% | 0.00% | 0.0% |
| Q1 2020 | $672,000 | +30.0% | 16,518 | +97.3% | 0.00% | – |
| Q4 2019 | $517,000 | +4.0% | 8,372 | +22.7% | 0.00% | – |
| Q3 2019 | $497,000 | -7.6% | 6,822 | +4.2% | 0.00% | – |
| Q2 2019 | $538,000 | +5.1% | 6,549 | -9.7% | 0.00% | – |
| Q1 2019 | $512,000 | +48.8% | 7,250 | -5.3% | 0.00% | – |
| Q4 2018 | $344,000 | +0.3% | 7,657 | +26.2% | 0.00% | – |
| Q3 2018 | $343,000 | -40.7% | 6,066 | -29.9% | 0.00% | -100.0% |
| Q2 2018 | $578,000 | +50.1% | 8,659 | +30.6% | 0.00% | – |
| Q1 2018 | $385,000 | -20.6% | 6,631 | -11.8% | 0.00% | – |
| Q4 2017 | $485,000 | -20.8% | 7,519 | -35.5% | 0.00% | -100.0% |
| Q3 2017 | $612,000 | +127.5% | 11,655 | +103.3% | 0.00% | – |
| Q2 2017 | $269,000 | -53.5% | 5,734 | -50.9% | 0.00% | -100.0% |
| Q1 2017 | $578,000 | -31.8% | 11,670 | -16.6% | 0.00% | 0.0% |
| Q4 2016 | $847,000 | +4.7% | 13,998 | +14.9% | 0.00% | 0.0% |
| Q3 2016 | $809,000 | -36.7% | 12,188 | -46.8% | 0.00% | 0.0% |
| Q2 2016 | $1,279,000 | +63.3% | 22,909 | -1.6% | 0.00% | 0.0% |
| Q1 2016 | $783,000 | -48.8% | 23,289 | -31.3% | 0.00% | -50.0% |
| Q4 2015 | $1,529,000 | +220.5% | 33,914 | +181.3% | 0.00% | +100.0% |
| Q3 2015 | $477,000 | -68.0% | 12,055 | -49.8% | 0.00% | 0.0% |
| Q2 2015 | $1,490,000 | +60.9% | 24,015 | +62.2% | 0.00% | 0.0% |
| Q1 2015 | $926,000 | +4.5% | 14,804 | -5.8% | 0.00% | 0.0% |
| Q4 2014 | $886,000 | +119.9% | 15,716 | +10.3% | 0.00% | – |
| Q3 2014 | $403,000 | -70.1% | 14,244 | -63.5% | 0.00% | -100.0% |
| Q2 2014 | $1,346,000 | +110.3% | 39,072 | +91.1% | 0.00% | 0.0% |
| Q1 2014 | $640,000 | – | 20,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |